Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
9 Feb 2026
Asthma Microbiome Patterns Vary Worldwide, Study Finds
Global research shows asthma microbiome and airway inflammation differ by region, but neutrophilic asthma shows consistent bacterial patterns.
9 Feb 2026
Frozen Embryo Transfer Linked to Hypertension Risk
Frozen embryo transfer demonstrated comparable perinatal outcomes to fresh transfer but was associated with a higher risk of pregnancy induced hypertension in IVF conceived pregnancies.
9 Feb 2026
Vunakizumab Shows Promise for Active Psoriatic Arthritis
A phase 2 trial found vunakizumab improved ACR20 response rates in active psoriatic arthritis, with sustained benefits and a favourable safety profile.
9 Feb 2026
Atopic Dermatitis Linked to Higher Global Burden of Asthma and Rhinitis
Global analysis finds people with atopic dermatitis have significantly higher rates of asthma and rhinitis, highlighting the need for integrated respiratory screening.
9 Feb 2026
One-Third of Dementia Cases Linked to Non-Brain Diseases
Study shows non-brain diseases such as diabetes, hearing loss, and liver disease, account for nearly one-third of dementia cases worldwide.
9 Feb 2026
Epigenetic Therapy Alters Tumour Microenvironment in Ovarian Cancer
Epigenetic therapy combined with immunotherapy reshaped the tumour microenvironment in platinum-resistant ovarian cancer, promoting inflammatory immune signalling and disease control in half of treated patients.
9 Feb 2026
HIV Vaccine Candidate Triggers Rapid Neutralising Antibodies
A novel HIV vaccine candidate induces neutralising antibodies after a single dose in primates, potentially accelerating HIV prevention strategies.
9 Feb 2026
CosmeRNA in Androgenetic Alopecia
This educational video explores CosmeRNA, an RNA-based cosmetic approach for managing androgenetic alopecia. Mukta Sachdev, Head of…
8 Feb 2026
Personalised T Cell Activator Shows Promise
A personalised multipeptide T cell activator induced durable immune responses and showed an acceptable safety profile in patients with chronic lymphocytic leukaemia in a phase one trial.
8 Feb 2026
New Research into Oral Semaglutide and Heart Failure Outcomes
The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.
←
1
2
3
4
5
6
7
8
9
10
…
1,376
1,377
1,378
→
We’ve noticed you’re accessing
from
North/South America.
View
View